Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/181212
Full metadata record
DC FieldValueLanguage
dc.contributor.authorRao, K. S. Jagannatha-
dc.contributor.authorBritton, Gabrielle B.-
dc.contributor.authorRocha Arrieta, Luisa Lilia-
dc.contributor.authorGarcia-Cairasco, Norberto-
dc.contributor.authorLazarowski, Alberto-
dc.contributor.authorPalacios, Adrián-
dc.contributor.authorCamins Espuny, Antoni-
dc.contributor.authorMaccioni, Ricardo B-
dc.date.accessioned2021-11-11T11:21:13Z-
dc.date.available2021-11-11T11:21:13Z-
dc.date.issued2021-07-24-
dc.identifier.issn1387-2877-
dc.identifier.urihttp://hdl.handle.net/2445/181212-
dc.description.abstractPerhaps one of the most significant scientific challenges is to understand the human brain. Neuroscience research has had a considerable impact on individuals, families, and society. However, before we can have a real impact on public health, we need a greater understanding of biological processes that underlie the wide variety of neurological and psychiatric disorders such as Alzheimer's disease (AD), Parkinson's disease, schizophrenia, depression, traumatic brain injury, epilepsy, and many others. It is a great challenge and responsibility of science to unravel the brain's secrets through translational research and drug discovery in order to improve the lives of individuals with these devastating conditions. In the past decade, outstanding discoveries have been made that have made possible novel and multidisciplinary approaches to understanding the brain's mysteries.-
dc.format.extent4 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherIOS Press-
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.3233/JAD-210245-
dc.relation.ispartofJournal of Alzheimer's Disease, 2021, vol. 82, , num. s1, p. 1-4-
dc.relation.urihttps://doi.org/10.3233/JAD-210245-
dc.rights(c) Rao, K. S. Jagannatha et al., 2021-
dc.sourceArticles publicats en revistes (Farmacologia, Toxicologia i Química Terapèutica)-
dc.subject.classificationCervell-
dc.subject.classificationMalalties neurodegeneratives-
dc.subject.classificationNeurociències-
dc.subject.otherBrain-
dc.subject.otherNeurodegenerative Diseases-
dc.subject.otherNeurosciences-
dc.titleTranslational Research and Drug Discovery for Neurodegeneration: Challenges for Latin America-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.identifier.idgrec714434-
dc.date.updated2021-11-11T11:21:13Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
Appears in Collections:Articles publicats en revistes (Farmacologia, Toxicologia i Química Terapèutica)

Files in This Item:
File Description SizeFormat 
714434.pdf51.83 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.